Lingxue Kong was awarded his Ph.D. from the University of New South Wales in Australia in 1997. One of his research interests lies in the development of nanomaterials for colorectal cancers by incorporating targeting reagents to improve the efficacy of drugs. He has published more than 245 scientific articles in leading international journals with a citation of more than 5500 and an h-index of 41.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
